Beattie Nell

Avg. Two Year Performance

11% Avg. Purchase Return
5% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return5%22%16%109%11%
Purchase Success Rate3 of 41 of 42 of 42 of 41 of 4
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

CFO, Head of Corp. Development, Director:

Holdings: 68.2K shares


Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount